Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06830486 · ClinicalTrials.gov registry record
Effects of Activity on Diabetes Risk Among Breast Cancer Survivors on Endocrine Therapy (ABIDE)
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 40
- Enrollment target
NCT06830486: Completed study, sponsored by University of Colorado, Denver.
NCT06830486 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06830486 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The aim of this study is to learn more about how physical activity and cardiorespiratory fitness are related to diabetes risk among breast cancer patients prescribed an endocrine therapy.
Primary Outcome
Insulin resistance will be measured through oral glucose tolerance testing
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-02-14 |
| Est. Completion | 2023-10-31 |
What the finished NCT06830486 record still lists
NCT06830486 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT06830486 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06830486 about?
NCT06830486 is a clinical study titled "Effects of Activity on Diabetes Risk Among Breast Cancer Survivors on Endocrine Therapy (ABIDE)". The aim of this study is to learn more about how physical activity and cardiorespiratory fitness are related to diabetes risk among breast cancer patients prescribed an endocrine therapy.
What is the current status of trial NCT06830486?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2022-02-14. Estimated completion is 2023-10-31.
What interventions are being tested in trial NCT06830486?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT06830486?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI